Radiotherapy for Graves' orbitopathy: Randomised placebo-controlled study

Lancet

Volumn 355, Issue 9214, 2000, Pages 1505-1509

  Mourits, Maarten P ^a   Van Kempen Harteveld, M Loes ^a   García García, M Begoña ^a   Koppeschaar, Hans P F ^a   Tick, Lidwine ^a   Terwee, Caroline B ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BINOCULAR VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DOUBLE BLIND PROCEDURE; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE DISEASE; EYELID; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STRABISMUS SURGERY; TREATMENT OUTCOME;

EID: 0034728880     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02165-6     Document Type: Article

References (29)

1. Mourits M.P., Koornneef L., Wiersinga W.M., Prummel M.F., Berghout A., van der Gaag R. Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology. 97:1990;636-641.
2. Terwee C.B., Gerding M.N., Dekker F.W., Prummel M.F., Wiersinga W.M. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy. the GO-QOL Br J Opthalmol. 82:1998;773-779.
3. Gerding M.N., Terwee C.B., Dekker F.W., Koornneef L., Prummel M.F., Wiersinga W.M. Quality of life in patients with Graves' ophthalmopathy is markedly decreased. measurements by the Medical Outcome Study instrument Thyroid. 7:1997;885-889.
4. Burch H.B., Wartofsky L. Graves' ophthalmopathy. current concepts regarding pathogenesis and management Endocr Rev. 14:1993;747-793.
5. Leone C.h.R. Jr. The management of ophthalmic Graves' disease. Ophthalmology. 91:1984;770-779.
6. Prummel M.F., Mourits M.P., Berghout A.et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med. 321:1989;1353-1359.
7. Dandona P., Marshall N., Bidey S., Nathan A.W., Havard C.W.H. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. BMJ. i:1979;374-376.
8. Baschieri L., Antonelli A., Nardi S.et al. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. Thyroid. 7:1997;579-585.
9. Krassas G.E., Dumas A., Pontikedes N. Kaltsas Th. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol (Oxf). 42:1995;571-580.
10. Donaldson S.S., Bagshaw M.A., Kriss J.P. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab. 37:1973;276-285.
11. Bartalena L., Marcocci C., Laddaga M.et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy. comparison with systemic corticosteroids alone J Clin Endocrinol Metab. 56:1983;1139-1144.
12. Prummel M.F., Mourits M.P., Blank L., Koornneef L., Wiersinga W.M. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet. 342:1993;949-954.
13. Meinert C.L. Beyond CONSORT. need for improved reporting standards for clinical trials JAMA. 279:1998;1487-1491.
14. Olivotto L.A., Lugdate C.M., Allen L.H., Rootman J. Supervoltage orbital radiotherapy for Graves' orbitopathy. CCABC Technique and results Int J Radiat Oncol Biol Phys. 11:1985;2085-2090.
15. Prummel M.F., Wiersinga W.M. Smoking and risk of Graves' disease. JAMA. 269:1993;479-482.
16. Gerding M.N., Prummel M.F., Kalmann R., Koornneef L., Wiersinga W.M. The use of colour slides in the assessment of changes in soft-tissue involvement in Graves' orbitopathy. J Endocrinol Invest. 21:1998;459-462.
17. Mourits MP, Lombardo S. Hertel value distribution in Caucasian Graves' patients and controls. Poster presented at the 6th International Symposium on Graves' ophthalmopathy, Amsterdam, Nov, 27, to, Nov, 28, 1998.
18. Mourits M.P., Prummel M.F., Wiersinga W.M., Koornneef L. Measuring eye movements in Graves' ophthalmology. Ophthalmology. 101:1994;1341-1346.
19. Mein J., Trimble R. Diagnosis and management of ocular motility disorders. 1991;86 Blackwell Scientific Publications, Oxford.
20. Duke-Elder S., Smith R.J.H. The examination of the visual functions. Duke-Elder S. The foundations of ophthalmology: hereditary, pathology, diagnosis, and therapeutics. System of Ophthalmology, vol 7. 1962;370-373 CV Mosby, St Louis.
21. Mourits M.P., Prummel M.F., Wiersinga W.M., Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf). 47:1997;9-14.
22. Bartalena L., Marcocci C., Bogazzi F.et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med. 338:1998;73-78.
23. Paridaens D., Hans K., Van Buitenen S., Mourits M.P. The incidence of diplopia following coronal and translid orbital decompression in Graves' orbitopathy. Eye. 12:1998;800-805.
24. Werner S.C. Modification of the classification of eye changes of Graves' disease. recommendations of the adhoc Committee of the American Thyroid Association J Clin Endocrinol Metab. 44:1977;204-205.
25. Gorman C.A. Clever is not enough. NO SPECS is form in search of function Thyroid. 1:1991;353-355.
26. Bahn R.S., Gorman C.A. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalopathy. Endocrinol Metab Clin North Am. 16:1987;391-407.
27. Kinyoun J.L., Kalina R.E., Brower S.A., Mill R.P., Johnson R.H. Radiation retinopathy following orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol. 102:1984;1473-1476.
28. Viebahn M., Barricks M.E., Osterloh M.D. Synergism between diabetic and radiation retinopathy. case report and review Br J Ophthalmol. 75:1991;629-632.
29. Bartley G.B. The treatment of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 121:1996;200-206.